The total immune response made by an organism on encountering an antigen is conditioned by previous exposure to that antigen and, to a lesser extent, by exposure to other antigens. Conventional immune reactions may thus be augmented (in the secondary response), reduced (by immune tolerance or immune competition), or selectively modified (by immune deviation).
The experimental arthritis of adjuvant disease in the rat is probably immunologically determined, being a cell-mediated response to the same antigenic component of the tubercle bacillus (TBC) which endows this organism with its conventional adjuvant properties. The predominantly articular distribution of the lesions is presumably due to local joint conditions in some way favouring the settling out there of minute fragments of mycobacteria absorbed from the injection site.
As with other immune reactions, adjuvant arthritis can be modified by previous exposure to the responsible antigen. It is prevented by the administration of TBC either in the neonatal period (Houssay and Frangione, 1961) , or during the period immediately before the sensitizing injection (Gery and Waksman, 1967) ; and it can be reduced by immune competition (Pear'son and Wood, 1962) .
Most interest in the modification of immune responses by the administration of antigen has centred on experiments in which the modifying dose is given before the definitive antigenic challenge. However, consideration of the possibility that this type of immune manipulation may offer an approach to the treatment of immunologically determined disease raises the question of the extent to which it is possible to modify reactions already under way. This principle is already applied in the treatment of atopic disorders by 'desensitizing' injections, which stimulate the production of blocking antibody. The question therefore arises whether other types of immunopathological processes may be inhibited by using antigenic stimulation to modify the immune status of the subject.
To explore this possibility in an experimental disease model, an attempt has been made to modify the course of adjuvant arthritis in the rat by injection of either whole TBC or tuberculin (protein purified derivative-PPD) given during the incubation period of the disease. In the event, whole TBC protected the animals from the disease, while PPD tended to aggravate the lesions.
Methods and materials
Animals Colony-bred strains of Sprague-Dawley, Hooded, and Wistar rats of either sex, but weighing over 150 g. were employed. In any one experiment, all groups consisted of the same strain and sex, and groups were approximately matched for weight.
Induction of arthritis Each animal received an intracutaneous injection into the right hind foot-pad, consisting of 0-6 mg. dried heatkilled TBC (Central Veterinary Laboratory, Weybridge) homogenized in 0 1 ml. heavy mineral oil (liquid paraffin, B.P.). The injection was made on 'Day 0'.
Quantitation of arthritis
The method used for scoring joints has been described (Currey and Ziff, 1968 
Skin testing
The same preparations of TBC and PPD used for intraperitoneal injections were diluted to 1 mg./ml. and 10,000 u. (0-2 mg.)/ml. respectively and, using a very fine (30 gauge) needle, 0 -02 ml. of these dilutions were each injected into the pinna of one ear of animals to be tested. A micrometer was employed to measure the thickness of the ear at the injection site immediately before the injection, and 24 and 48 hours later.
Results Fig. 1 two groups. Then, once the clinical lesions appeared, the TBC group gained weight steadily, compared to marked loss of weight in the control group, and an even greater loss in the PPD-treated animals. These weight changes correlated with the general appearance of the rats, the TBC group being more vigorous, and clearly having been protected, in a general sense, from the disease.
A series of further experiments showed these results to be reproducible. Although the severity of the adjuvant arthritis varied considerably from experiment to experiment (depending on the strain of rat, the batch of adjuvant, and apparently other, undefined variables), nevertheless the trends observed in this first experiment were consistent.
With the method of scoring employed, the high joint scores recorded in control animals meant that there was little scope for the arthritis-aggravating influence of PPD to be apparent. However, when a less sensitive strain of rat was used, the PPD-treated animals developed an obviously more severe arthritis. Such an experiment is illustrated in Fig. 2 . Variationi in the route of injection Experiments in which the intraperitoneal injections were replaced by the same substances given by intramuscular injection, gave variable results which were difficult to interpret. In general it appeared that intramuscular injections were a less effective method of producing a qualitatively similar effect.
Injection of other suibstances
The effect was studied of giving intraperitoneal injections of other substances on Day + 5. These included a range of doses of pertussis vaccine, aluminium hydroxide gel, and washed sheep red blood cell suspensions given both as a primary and as a secondary challenge. These injections introduced considerably more variation in the severity of the subsequent arthritis, and all three substances, in individual experiments, appeared to produce some aggravation of the arthritis. However, no consistent trend was apparent comparable to that seen with TBC or PPD.
Skin testing with TBC and PPD Rats injected with Freund's complete adjuvant in the manner necessary to produce arthritis, also develop delayed-type skin responses to both PPD and whole TBC in suspension. This is conveniently quantitated by the ear injection technique described above under Methods. Fig. 3 shows the results of an experiment similar in design to that illustrated in Fig. 1 (Rich, 1951) .
The question arises whether TBC-induced inhibition of adjuvant arthritis may depend on a mechanism similar to that mediating the immune deviation described by Asherson and Stone (1965) . These authors showed that the immune response to an antigen administered to guinea-pigs in Freund's complete adjuvant was modified by injecting the same antigen as an aqueous preparation beforehand. This led to a reduction in delayed-type sensitivity and a qualitative alteration in the antibody produced. The effect was still apparent if the modifying injection was delayed until the day after the injection of antigen in complete Freund's adjuvant, but not if it were delayed until the sixth day. Crowle and Hu (1966) have described a somewhat similar modification of the immune response (split tolerance) seen in mice after the injection of antigen in a water-in-oil emulsion. This could be achieved by aqueous preparations of the antigen administered, not only beforehand but up to as long as 2 weeks after the definitive challenge.
The present experiments did not include the administration of intraperitoneal TBC before inducing arthritis, but Gery and Waksman (1967) have shown that pre-treatment with a course of TBC-insaline injections effectively prevents arthritis appearing, although it does not prevent the PPD skin test becoming positive. Interestingly, these pre-treated rats will develop arthritis if injected with lymphocytes from appropriately sensitized donors, but if they themselves receive the sensitizing injection, their lymphocytes will not produce arthritis when injected into normal recipients.
Another experimental disease which has been successfully suppressed by the administration of antigen is allergic encephalomyelitis. Administration of brain tissue to rats either during the neonatal period (Paterson, 1958) or to adult rats receiving cyclophosphamide (Salvin and Liauw, 1968 ) induces a state of tolerance to the responsible antigen, which protects the animals against a subsequent encephalitogenic challenge. More relevant to the present work is the observation by Alvord, Shaw, Hruby, and Kies (1965) that this disease can be prevented or suppressed by injection of nervous tissue (particularly as a water-in-oil suspension) given either before or after the encephalitogenic challenge. Even when injections were delayed until clinical signs had appeared, there was some suppression. It is of interest that, in this better defined model, the inhibition of encephalitis correlated with a decrease in the delayed skin response and an increase in the serum antibody titre to nervous tissue. However, the mechanism which brings about these changes is still uncertain.
The significance to the clinician of studies such as these are obviously the therapeutic possibilities which they raise. The inhibition of experimental encephalomyelitis might, for example, be relevant to the treatment of demyelinating diseases. The inhibition of adjuvant arthi itis described here is a reminder that, in the rheumatological field also, administration of specific antigen may offer an approach to the suppression of immune-mediated disease. Summary Adjuvant arthritis in the rat was inhibited by the intraperitoneal injection, during the incubation period, of 100 mcg. or more of dead tubercle bacilli in suspension.
By contrast, tuberculin (PPD) in doses of 4 to 100 mcg. accentuated the lesions. Pertussis vaccine, aluminium hydroxide gel, and sheep erythrocytes produced less marked and inconsistent effects.
It is suggested that the inhibitory effect of mycobacteria injected in this way may be due to the peritoneal cavity providing a sump in which specifically instructed immunocytes are trapped, leaving insufficient numbers to mount a reaction elsewhere. I1 est suggere que l'effet inhibiteur de mycobact6ries injectees de cette fa$on peut etre du a ce que la cavite p6riton6ale fournit un r6servoir dans lequel des immunocytes sp6cifiquement choisis sont bloqu6s laissant ainsi un nombre insuffisant pour commencer une reaction ailleurs.
Modificaci6n de la artritis adyuvante en la rata por inyecciones intraperitoneales de microbacteria muerta o de tuberculina La artritis adyuvante en la rata fue inhibida, durante el periodo de incubacion, mediante la inyecci6n intraperitoneal de 100 mcg. o mas de bacilo tuberculoso muerto, en suspensi6n.
Por contraste, la tuberculina (PPD) en dosis de 4 a 100 mcg. acentu6 las lesiones. La vacuna de tos ferina, la gel de hidroxido de aluminio y los eritrocitos de oveja produjeron efectos menos marcados e inconsistentes.
Se sugiere que le efecto inhibitorio de microbacteria inyectada de este modo quiza se deba a que la cavidad peritoneal ofrece un pozo colector en el cual quedan atrapados inmunocitos especfficamente aleccionados, dejando libres cantidades insuficientes para producir una reacci6n en otro punto. 
